Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid

D. J. Stewart, J. A. Benvenuto, M. Leavens, S. W. Hall, Robert S Benjamin, W. Plunkett, K. B. McCredie, M. A. Burgess, T. L. Loo

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The antitumor agent 3-deazauridine (DAU) was administered rapidly to four patients before surgical removal of intracerebral tumor. Tumor, adjacent brain tissue, and temporalis muscle were assayed for DAU by high-pressure liquid chromatogrphy. DAU penetrated comparably into tumor, brain, and muscle; in one patient, tissue concentrations were higher than concurrent plasma concentrations. The active metabolite 3-deazauridine 5'-triphosphate was quantitated in one tumor sample and greatly exceeded its K(i) for cytidine 5'-triphosphate synthetase. DAU was also present in autopsy brain specimens from two patients treated shortly anetmortem. Cerebrospinal fluid concentrations were 22.1 and 59.0%, respectively, of concurrent plasma concentrations during continuous infusion of DAU in two patients. Cerebrospinal fluid concentration was 3.1 μg/ml 2 hr after a 30-min infusion of 1.5 g of drug per sq m and fell to 1.9 μg/ml at 16 hr. Thus, DAU is capable of penetrating into intracerebral tumor, brain, and cerebrospinal fluid and is worthy of investigation in the treatment of intracerebral and meningeal neoplasms.

Original languageEnglish (US)
Pages (from-to)4119-4122
Number of pages4
JournalCancer Research
Volume39
Issue number10
StatePublished - 1979

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid'. Together they form a unique fingerprint.

Cite this